Healthcare industry

Project partners in developing countries will from now on be able to receive DFG funding.

Press release - 24/10/2011

Curetis AG Opens Unyvero™ Cartridge Production Facility

Curetis AG, an innovative molecular diagnostics company focusing on the development and commercialization of in-vitro diagnostic products for infectious diseases, announced the opening of its state-of-the-art production facility for disposable Unyvero™ cartridges in Bodelshausen (near Tuebingen, Germany).

Worldwide less than 10000 people suffer from Gauchers disease which is the most common lysosomal storage disease. Genzyme has been offering the drug Cerezyme for the treatment of this rare genetic disease since 1994. The companys subsidiary in Constance markets and sells this enzyme replacement therapy in Europe and Asia. The active substance is produced in Chinese hamster ovary cell cultures.

Press release - 26/11/2014

Curetis Closes EUR 14.5 Million Extension of Series B Financing

Curetis AG wins new investors QIAGEN and LSP-HEF, committing EUR 7 million. Hence Curetis is well financed into 2017. Curetis AG, a developer of next-level molecular diagnostic solutions, today announced it has closed a EUR 14.5 million extension of its Series B financing round, which was originally led by HBM Partners in April 2013.

The human olfactory system possesses a special electric amplification mechanism that enables olfactory cells to respond even to extremely weak stimuli. Scientists at Heidelberg University headed by physiologist Prof. Dr. Stephan Frings have now established how this mechanism works. Crucial is the role played by chloride ions stored in the sensory cilia of the nose. As soon as the olfactory receptors in the sensory cilia detect odorants the…

Press release - 05/12/2011

Flexible Rack Systems Sort Molecules

Researchers of Karlsruhe Institute of Technology (KIT) and Ruhr-Universität Bochum (RUB) have developed a flexible and efficient new process for the separation of enantiomers. Enantiomer separation is indispensable for the production of many pharmaceuticals. In their process, the scientists use porous molecular frameworks (MOFs) that are assembled in layers on solid substrates using a specifically developed method. The results have now been…

Press release - 09/02/2012

European tool enables companies to open up markets

BioRegio STERN Management GmbH is one of five project partners in BIOMAT-In. This transnational EU project promotes innovations and cooperation in the biomaterials sector and is being funded for three years with a total of EUR 1.24 million. BioRegio STERN Management GmbH is committed to creating a successful pan-European cluster in regenerative medicine and tissue engineering. It is receiving EUR 223,000 during this period to develop a…

Press release - 08/07/2010

EMBL: Digital Embryo gains wings

The scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, who ‘fathered’ the Digital Embryo have now given it wings, creating the Fly Digital Embryo. In work published today in Nature Methods, they were able to capture fruit fly development on film, and were the first to clearly record how a zebrafish’s eyes and midbrain are formed. The improved technique will also help to shed light on processes and organisms,…

A new Clinical Research Unit at the University of Ulm is to investigate the early inflammation response and the positive impact on the immune system in casualty injuries. The insights gained will be transferred to patients.

At the end of the year Alessandro Banchi 62 Chairman of the Board of Directors at Boehringer Ingelheim GmbH and head of Marketing and Sales is to be succeeded by the Vice-Chairman of the Board of Managing Directors Dr. Andreas Barner 55.

Press release - 26/11/2012

Functional Magnetic Resonance Imaging under the Magnifying Glass

Jozien Goense from the Max Planck Institute for Biological Cybernetics in Tübingen Germany and her colleagues used functional Magnetic Resonance Imaging fMRI to observe these layer-specific neural processes within the cortex and found different mechanisms for fMRI response increases and decreases as well as cortical layer-dependent differences in the neurovascular coupling mechanism.

Among the 20 winners in the first round of the BMBF contest Health Regions of the Future were five concepts from Baden-Württemberg. In the coming nine months the chosen health regions will turn their concepts into full proposals.

Scientists of the German Cancer Research Center DKFZ in Heidelberg have now shown that inspection of both sides of the colon also reduces cancer risk in the right part of the colon by more than 50 percent. The overall risk was found to be 77 percent lower. This means that colonoscopy provides very good protection from colon cancer - even though it is not a 100 percent guarantee.

A study carried out by an international team of scientists, including scientists from the Freiburg University Medical Centre, pooled 16,000 probands and produced large datasets for the identification of genes with an elevated risk for Alzheimer’s disease.

Press release - 09/07/2010

Cytonet: where the German economy pulsates

The Top 100 distinguishes the most innovative companies in Germany. And this year Weinheim-based Cytonet GmbH Co. KG is among their number. Resourceful employees the courage to try new things and creative research spirit have taken this particular SME to the very top right into the list of the 100 top innovators in Germany.

Press release - 30/06/2009

febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment

In the near future, Next-Generation Sequencing technologies will lead to a rising number of completed genomes of model organisms and other species of interest, as demonstrated by the updated mouse genome. This accelerated development will generate a variety of tools available in the short term for the application of the new data into experiments. febit’s technology enables the conversion of new sequence data into biochips for gene expression…

Press release - 01/08/2012

Combination of businesses of SYGNIS and GENETRIX’ subsidiary X-Pol proposed

SYGNIS Pharma AG and GENETRIX announced today, that the biotechnology companies SYGNIS and GENETRIX have signed a binding Term Sheet under which the companies propose to combine the GENETRIX’ DNA sequencing subsidiary X-Pol Biotech and SYGNIS. Goal is to develop and market X-Pol Biotech, S.L.’s DNA sequencing technologies and products.

The German Cancer Research Centre and the Centre for Molecular Biology Heidelberg have created a new type of cooperation between the university and the Helmholtz Society. They hope that this will help increase their attractiveness to high-calibre scientists.

Press release - 09/09/2010

C&O Pharmaceutical Technology (Holdings) Ltd., Nanjing

Headquartered in Hong Kong and listed on the Singapore Exchange since October 2005 CO Pharmaceutical Technology Holdings Limited CO is an integrated pharmaceutical group in the Peoples Republic of China. The business model spans the entire value chain in the pharmaceutical industry which includes Reasearch and Development RD manufacturing marketing and distribution of CO branded respectively third party pharmaceutical products.

Karin Jurkat-Rott lecturer at the Institute for Applied Physiology at the University of Ulm has been awarded the Felix Jerusalem Award 2008 of the German Society for Muscular Disorders. The award worth 7500 euros recognises causal research and therapeutic approaches.

CureVac GmbH, the mRNA company, today announced that the Paul-Ehrlich-Institute, the German regulatory authority for medicinal products, has approved the start of a Phase IIa trial for CV9201 to treat Non-Small Cell Lung Cancer (NSCLC).

Press release - 04/03/2009

Federal funding for new stem cell project at the ZRM

Researchers in Tübingen have successfully cultivated germ cells of adult men to create pluripotent stem cells with a therapeutic potential similar to that of embryonic stem cells, but with much less potential for ethical conflict. Now, with funding from the German Federal Ministry of Education and Research, a new project has been launched to characterize these cells in depth and to explore their therapeutic application in regenerative medicine.

Proposals can be submitted up until 9th April 2008.

A wide spectrum of high quality support is available to young scientists in Germany. This is the conclusion of the government report on support for young scientists Bundesbericht zur Förderung des Wissenschaftlichen Nachwusches - BuWiN presented by the Federal Ministry of Education and Research.

Genedata AG has developed a modular software system known as Genedata Screener that is tailored to screening and hit-to-lead applications. Dr. Timo Wittenberg who works at the companys site in Constance Germany told us about the advantages of the software for identifying high-potential leads.